IMVT Operating Expenses

Immunovant Inc · Operating Expenses

IMVT logo

IMVT Operating Expenses

Latest reported$566.00M
IMVT Operating Expenses ($136.74M → $566.00M)
High-resolution chart · PNG

IMVT operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunovant Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
532,902,000
438,152,000
270,209,000
208,276,000
156,033,000
108,117,000
59,657,000
448
136,740,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.